Browse by Journal Title

Article

Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy.
Gross, S., Ihlow, J., Busack, L., Adamiak, K., Schrezenmeier, J., Jesse, J., Schwarz, M., Flörcken, A., Vuong, L.G., Rieger, K., Krönke, J., le Coutre, P., Boldt, V., von Brünneck, A.C., Horst, D., Burmeister, T., Blau, I.W., Keller, U., Bullinger, L. and Westermann, J.
Blood Cancer Journal 14 (1): 160. 16 September 2024

Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model.
Schwarzer, R., Nickel, N., Godau, J., Willie, B.M., Duda, G.N., Schwarzer, R., Cirovic, B., Leutz, A., Manz, R., Bogen, B., Dörken, B. and Jundt, F.
Blood Cancer Journal 4 : e217. 13 June 2014

Letter

The DNA methylation status of the TERT promoter differs between subtypes of mature B-cell lymphomas.
Kouroukli, A.G., Fischer, A., Kretzmer, H., Chteinberg, E., Rajaram, N., Glaser, S., Kolarova, J., Bashtrykov, P., Mathas, S., Drexler, H.G., Ohno, H., Ammerpohl, O., Jeltsch, A., Siebert, R. and Bens, S.
Blood Cancer Journal 13 (1): 98. 26 June 2023

MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia.
Krowiorz, K., Ruschmann, J., Lai, C., Ngom, M., Maetzig, T., Martins, V., Scheffold, A., Schneider, E., Pochert, N., Miller, C., Palmqvist, L., Staffas, A., Mulaw, M., Bohl, S.R., Buske, C., Heuser, M., Kraus, J., O'Neill, K., Hansen, C.L., Petriv, O.I., Kestler, H., Döhner, H., Bullinger, L., Döhner, K., Humphries, R.K., Rouhi, A. and Kuchenbauer, F.
Blood Cancer Journal 6 (12): e508. December 2016